Search

Your search keyword '"Henry, Julien"' showing total 176 results

Search Constraints

Start Over You searched for: Author "Henry, Julien" Remove constraint Author: "Henry, Julien"
176 results on '"Henry, Julien"'

Search Results

2. Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts

5. Automated Customized Bug-Benchmark Generation

9. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

10. Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study.

11. How to Compute Worst-Case Execution Time by Optimization Modulo Theory and a Clever Encoding of Program Semantics

13. PAGAI: a path sensitive static analyzer

14. Succinct Representations for Abstract Interpretation

15. Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis lesion: a case report and a narrative review of the literature.

17. Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicenter retrospective observational study

19. When the Decreasing Sequence Fails

20. Succinct Representations for Abstract Interpretation : Combined Analysis Algorithms and Experimental Evaluation

21. Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

22. Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study

23. ASTERICS: A Tool for the ExploRation and Integration of omiCS data

25. Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

26. Acute and Subacute Toxicity Studies of the Combination of the Aqueous Extracts of Trunk Bark of Musanga cecropioides R. Br. (Cecropiaceae) and Fruits of Picralima nitida (Stapf) T. Durand and H. Durand (Apocynaceae)

27. Rituximab Impairs B Cell Response But Not T Cell Response to COVID ‐19 Vaccine in Autoimmune Diseases

29. Dénosumab dans le pied de Charcot actif

31. Additional file 1 of Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls

35. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

36. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

39. Acute and Subacute Toxicity Studies of the Combination of the Aqueous Extracts of Trunk Bark of Musanga cecropioides R. Br. (Cecropiaceae) and Fruits of Picralima nitida (Stapf) T. Durand and H. Durand (Apocynaceae)

43. Sparse and inconsistent reporting of pre‐ and post‐operative radiographic angles of total knee arthroplasty using true unrestricted kinematic alignment: An umbrella review and secondary meta‐analysis.

45. L'historien et le jeu vidéo. L'exemple de Versailles 1685 : complot à la cour du roi soleil

48. Automated Customized Bug-Benchmark Generation

Catalog

Books, media, physical & digital resources